Exenatide
Common brands: Byetta, Metformin Hcl, Metformin Hydrochloride, Lantus, Metformin
Top reporter: Astrazeneca Pharmaceuticals Lp
GLP-1 Receptor Agonist [EPC]Sulfonylurea [EPC]Insulin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]
52,309
Total Reports
2,422
Serious Reports
1,762
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.37%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Exenatide.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | BLOOD GLUCOSE INCREASED | 15,474 | |
| 2 | WEIGHT DECREASED | 12,124 | |
| 3 | NAUSEA | 12,043 | |
| 4 | DECREASED APPETITE | 5,643 | |
| 5 | BLOOD GLUCOSE DECREASED | 5,517 | |
| 6 | VOMITING | 4,347 | |
| 7 | DIARRHOEA | 2,742 | |
| 8 | DIZZINESS | 2,674 | |
| 9 | DRUG INEFFECTIVE | 2,250 | |
| 10 | HEADACHE | 2,086 | |
| 11 | INJECTION SITE PAIN | 2,023 | |
| 12 | PANCREATITIS | 2,011 | |
| 13 | INJECTION SITE BRUISING | 1,843 | |
| 14 | INJECTION SITE HAEMORRHAGE | 1,809 | |
| 15 | FATIGUE | 1,760 | |
| 16 | FEELING ABNORMAL | 1,665 | |
| 17 | INCORRECT DOSE ADMINISTERED | 1,631 | |
| 18 | MALAISE | 1,596 | |
| 19 | ASTHENIA | 1,540 | |
| 20 | DRUG EFFECT DECREASED | 1,525 | |
| 21 | TREMOR | 1,519 | |
| 22 | DYSPEPSIA | 1,374 | |
| 23 | WEIGHT INCREASED | 1,370 | |
| 24 | ABDOMINAL DISTENSION | 1,311 | |
| 25 | ABDOMINAL PAIN UPPER | 1,251 | |
| 26 | PANCREATIC CARCINOMA | 1,186 | |
| 27 | CONSTIPATION | 1,177 | |
| 28 | HYPERHIDROSIS | 1,109 | |
| 29 | OFF LABEL USE | 1,109 | |
| 30 | GLYCOSYLATED HAEMOGLOBIN INCREASED | 991 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.